Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00269-8/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz--Oj5PFObXwhc-OHSgf-Y-x-JM3ievAauw-XcIe2RFg5nslP58Vb7GBvjhziH1YNBQ80cll7cBW9BnJ6m3ey5I1qQD9jw&_hsmi=347684716&utm_content=347674072&utm_source=hs_email